Report Detail
COVID-19 Impact on Global Precision Cancer Tests Market Size, Status and Forecast 2020-2026
- RnM3984834 |
- 03 June, 2020 |
- Global |
- 92 Pages |
- QYResearch |
- Other
Precision cancer tests encompass imaging and in vitro diagnostic products and procedures that directly detect malignancies in patient samples or in the patients themselves.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Precision Cancer Tests market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Precision Cancer Tests industry.
Based on our recent survey, we have several different scenarios about the Precision Cancer Tests YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Precision Cancer Tests will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Precision Cancer Tests market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Precision Cancer Tests market in terms of revenue.
Players, stakeholders, and other participants in the global Precision Cancer Tests market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Precision Cancer Tests market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Precision Cancer Tests market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Precision Cancer Tests market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Precision Cancer Tests market.
The following players are covered in this report:
Abbott
BD
Bio-Rad
Cynvenio Biosystems
Foundation Medicine
Genomic Health
Illumina
Myriad Genetics
NanoString Technologies
QIAGEN
Randox Laboratories
Roche
Philips
Thermo Fisher Scientific
Precision Cancer Tests Breakdown Data by Type
Imaging
In Vitro Diagnostic
Others
Precision Cancer Tests Breakdown Data by Application
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Others
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Precision Cancer Tests Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Precision Cancer Tests Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Imaging
- 1.4.3 In Vitro Diagnostic
- 1.4.4 Others
- 1.5 Market by Application
- 1.5.1 Global Precision Cancer Tests Market Share by Application: 2020 VS 2026
- 1.5.2 Cancer Research Centers
- 1.5.3 Cancer Hospital
- 1.5.4 Surgical Centers
- 1.5.5 Clinics
- 1.5.6 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Precision Cancer Tests Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Precision Cancer Tests Industry
- 1.6.1.1 Precision Cancer Tests Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Precision Cancer Tests Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Precision Cancer Tests Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Precision Cancer Tests Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends by Regions
- 2.1 Precision Cancer Tests Market Perspective (2015-2026)
- 2.2 Precision Cancer Tests Growth Trends by Regions
- 2.2.1 Precision Cancer Tests Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Precision Cancer Tests Historic Market Share by Regions (2015-2020)
- 2.2.3 Precision Cancer Tests Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Precision Cancer Tests Market Growth Strategy
- 2.3.6 Primary Interviews with Key Precision Cancer Tests Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Precision Cancer Tests Players by Market Size
- 3.1.1 Global Top Precision Cancer Tests Players by Revenue (2015-2020)
- 3.1.2 Global Precision Cancer Tests Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Precision Cancer Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Precision Cancer Tests Market Concentration Ratio
- 3.2.1 Global Precision Cancer Tests Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Precision Cancer Tests Revenue in 2019
- 3.3 Precision Cancer Tests Key Players Head office and Area Served
- 3.4 Key Players Precision Cancer Tests Product Solution and Service
- 3.5 Date of Enter into Precision Cancer Tests Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Precision Cancer Tests Historic Market Size by Type (2015-2020)
- 4.2 Global Precision Cancer Tests Forecasted Market Size by Type (2021-2026)
5 Precision Cancer Tests Breakdown Data by Application (2015-2026)
- 5.1 Global Precision Cancer Tests Market Size by Application (2015-2020)
- 5.2 Global Precision Cancer Tests Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Precision Cancer Tests Market Size (2015-2020)
- 6.2 Precision Cancer Tests Key Players in North America (2019-2020)
- 6.3 North America Precision Cancer Tests Market Size by Type (2015-2020)
- 6.4 North America Precision Cancer Tests Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Precision Cancer Tests Market Size (2015-2020)
- 7.2 Precision Cancer Tests Key Players in Europe (2019-2020)
- 7.3 Europe Precision Cancer Tests Market Size by Type (2015-2020)
- 7.4 Europe Precision Cancer Tests Market Size by Application (2015-2020)
8 China
- 8.1 China Precision Cancer Tests Market Size (2015-2020)
- 8.2 Precision Cancer Tests Key Players in China (2019-2020)
- 8.3 China Precision Cancer Tests Market Size by Type (2015-2020)
- 8.4 China Precision Cancer Tests Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Precision Cancer Tests Market Size (2015-2020)
- 9.2 Precision Cancer Tests Key Players in Japan (2019-2020)
- 9.3 Japan Precision Cancer Tests Market Size by Type (2015-2020)
- 9.4 Japan Precision Cancer Tests Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Precision Cancer Tests Market Size (2015-2020)
- 10.2 Precision Cancer Tests Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Precision Cancer Tests Market Size by Type (2015-2020)
- 10.4 Southeast Asia Precision Cancer Tests Market Size by Application (2015-2020)
11 India
- 11.1 India Precision Cancer Tests Market Size (2015-2020)
- 11.2 Precision Cancer Tests Key Players in India (2019-2020)
- 11.3 India Precision Cancer Tests Market Size by Type (2015-2020)
- 11.4 India Precision Cancer Tests Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Precision Cancer Tests Market Size (2015-2020)
- 12.2 Precision Cancer Tests Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Precision Cancer Tests Market Size by Type (2015-2020)
- 12.4 Central & South America Precision Cancer Tests Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Abbott
- 13.1.1 Abbott Company Details
- 13.1.2 Abbott Business Overview and Its Total Revenue
- 13.1.3 Abbott Precision Cancer Tests Introduction
- 13.1.4 Abbott Revenue in Precision Cancer Tests Business (2015-2020))
- 13.1.5 Abbott Recent Development
- 13.2 BD
- 13.2.1 BD Company Details
- 13.2.2 BD Business Overview and Its Total Revenue
- 13.2.3 BD Precision Cancer Tests Introduction
- 13.2.4 BD Revenue in Precision Cancer Tests Business (2015-2020)
- 13.2.5 BD Recent Development
- 13.3 Bio-Rad
- 13.3.1 Bio-Rad Company Details
- 13.3.2 Bio-Rad Business Overview and Its Total Revenue
- 13.3.3 Bio-Rad Precision Cancer Tests Introduction
- 13.3.4 Bio-Rad Revenue in Precision Cancer Tests Business (2015-2020)
- 13.3.5 Bio-Rad Recent Development
- 13.4 Cynvenio Biosystems
- 13.4.1 Cynvenio Biosystems Company Details
- 13.4.2 Cynvenio Biosystems Business Overview and Its Total Revenue
- 13.4.3 Cynvenio Biosystems Precision Cancer Tests Introduction
- 13.4.4 Cynvenio Biosystems Revenue in Precision Cancer Tests Business (2015-2020)
- 13.4.5 Cynvenio Biosystems Recent Development
- 13.5 Foundation Medicine
- 13.5.1 Foundation Medicine Company Details
- 13.5.2 Foundation Medicine Business Overview and Its Total Revenue
- 13.5.3 Foundation Medicine Precision Cancer Tests Introduction
- 13.5.4 Foundation Medicine Revenue in Precision Cancer Tests Business (2015-2020)
- 13.5.5 Foundation Medicine Recent Development
- 13.6 Genomic Health
- 13.6.1 Genomic Health Company Details
- 13.6.2 Genomic Health Business Overview and Its Total Revenue
- 13.6.3 Genomic Health Precision Cancer Tests Introduction
- 13.6.4 Genomic Health Revenue in Precision Cancer Tests Business (2015-2020)
- 13.6.5 Genomic Health Recent Development
- 13.7 Illumina
- 13.7.1 Illumina Company Details
- 13.7.2 Illumina Business Overview and Its Total Revenue
- 13.7.3 Illumina Precision Cancer Tests Introduction
- 13.7.4 Illumina Revenue in Precision Cancer Tests Business (2015-2020)
- 13.7.5 Illumina Recent Development
- 13.8 Myriad Genetics
- 13.8.1 Myriad Genetics Company Details
- 13.8.2 Myriad Genetics Business Overview and Its Total Revenue
- 13.8.3 Myriad Genetics Precision Cancer Tests Introduction
- 13.8.4 Myriad Genetics Revenue in Precision Cancer Tests Business (2015-2020)
- 13.8.5 Myriad Genetics Recent Development
- 13.9 NanoString Technologies
- 13.9.1 NanoString Technologies Company Details
- 13.9.2 NanoString Technologies Business Overview and Its Total Revenue
- 13.9.3 NanoString Technologies Precision Cancer Tests Introduction
- 13.9.4 NanoString Technologies Revenue in Precision Cancer Tests Business (2015-2020)
- 13.9.5 NanoString Technologies Recent Development
- 13.10 QIAGEN
- 13.10.1 QIAGEN Company Details
- 13.10.2 QIAGEN Business Overview and Its Total Revenue
- 13.10.3 QIAGEN Precision Cancer Tests Introduction
- 13.10.4 QIAGEN Revenue in Precision Cancer Tests Business (2015-2020)
- 13.10.5 QIAGEN Recent Development
- 13.11 Randox Laboratories
- 10.11.1 Randox Laboratories Company Details
- 10.11.2 Randox Laboratories Business Overview and Its Total Revenue
- 10.11.3 Randox Laboratories Precision Cancer Tests Introduction
- 10.11.4 Randox Laboratories Revenue in Precision Cancer Tests Business (2015-2020)
- 10.11.5 Randox Laboratories Recent Development
- 13.12 Roche
- 10.12.1 Roche Company Details
- 10.12.2 Roche Business Overview and Its Total Revenue
- 10.12.3 Roche Precision Cancer Tests Introduction
- 10.12.4 Roche Revenue in Precision Cancer Tests Business (2015-2020)
- 10.12.5 Roche Recent Development
- 13.13 Philips
- 10.13.1 Philips Company Details
- 10.13.2 Philips Business Overview and Its Total Revenue
- 10.13.3 Philips Precision Cancer Tests Introduction
- 10.13.4 Philips Revenue in Precision Cancer Tests Business (2015-2020)
- 10.13.5 Philips Recent Development
- 13.14 Thermo Fisher Scientific
- 10.14.1 Thermo Fisher Scientific Company Details
- 10.14.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
- 10.14.3 Thermo Fisher Scientific Precision Cancer Tests Introduction
- 10.14.4 Thermo Fisher Scientific Revenue in Precision Cancer Tests Business (2015-2020)
- 10.14.5 Thermo Fisher Scientific Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Precision Cancer Tests. Industry analysis & Market Report on COVID-19 Impact on Global Precision Cancer Tests is a syndicated market report, published as COVID-19 Impact on Global Precision Cancer Tests Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Precision Cancer Tests market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
